Business Context and Reporting Period
IM Cannabis Corp., an Israeli foreign private issuer, filed Form 6-K on November 13, 2023, for the month of November 2023. The filing identifies interim financial statements and management’s discussion and analysis for the nine months ended September 30, 2023 as exhibits.
The company files annual reports on Form 20-F. Principal executive offices are in Kibbutz Glil Yam, Israel.
Financial Metrics
The filing text provided is limited to the Form 6-K cover page and exhibit index. It does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus the Prior Comparable Period
The provided filing text does not describe material changes versus the prior comparable period.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
The provided text does not include guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in the attached management’s discussion and analysis.
Investor Verification Items
- Review Exhibit 99.2 for the interim consolidated financial statements for the nine months ended September 30, 2023.
- Review Exhibit 99.3 for management’s discussion and analysis, including operating trends, liquidity, risks, and outlook.
- Verify the company’s revenue, profitability, cash flow, debt, cash balances, and margin metrics in the interim financial statements.
- Review Exhibits 99.4 and 99.5 for the CFO and CEO certifications of the interim filings.